Michael Hurley

Conservation, nature-based impact funds raising €10bn - Phenix

Fund managers targeting positive impact through conservation and nature-based investments are currently raising a combined €10 billion ($12 billion), according to data provider Phenix Capital.

UK pensions' 'mixed' social investment record scrutinised by government

UK pensions trustees have been asked by the government to provide information on social factors of their investments after a senior minister expressed concern that these are currently "not well understood".

More than half of major US companies 'failing' on equal pay

More than half (26) of 51 of the largest US listed companies have been given a 'fail' grade for their inadequate progress to reduce the racial and gender pay gap, according to research by Arjuna Capital and Proxy Impact.

News round-up: TCFD, John Kerry, Legal and General, Church of England, and more

'Post-growth' investing could succeed unsustainable ESG strategies - ShareAction report

'Sustainable' investment approaches are merely a "continuation of unsustainable investment" practices insofar as they are built on the economic imperative of growth at a cost to society, according to a report by ShareAction and a group of UK charitable investors.

Asset owner climate valuation framework 'could be used by' IFRS

TPG targets 'next generation of diverse investors, entrepreneurs'

Alternatives investor TPG has launched an initiative to invest in what it called "the next generation of diverse investors and entrepreneurs".

JP Morgan private bank launches $150m impact fund

JP Morgan Private Bank has raised about $150 million at final close of its Global Impact Fund, to invest in areas including renewable energy, agriculture technology, education and financial inclusion.

TPG's Rise Fund invests $200m in Airtel Africa

TPG's Rise Fund is to invest $200 million in Airtel Africa's 'mobile money' business, as part of a deal which values the business at $2.65 billion.

M&G Catalyst impact strategy invests in vaccine developer

M&G was lead investor in a funding round worth $168 million in Vaccitech, which co-invented a Covid-19 vaccine with the University of Oxford.